Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
Utilizing AI and biobanking for drug target-biomarker validation in personalized melanoma treatment
| Reference number | 2024-02025 |
| Coordinator | Lunds universitet - Biomedicinsk teknik, avd f Biomedicinsk teknik |
| Funding from Vinnova | SEK 4 500 000 |
| Project duration | January 2025 - January 2028 |
| Status | Ongoing |
| Venture | European partnership for Personalised Medicine |
Last updated 12 December 2024
Reference number 2024-02025
